3 U.S. Insurance Stocks Worth Researching As Fed Rate Hike Odds Rise

Rising odds of fresh Fed rate hikes, sticky inflation and already painful borrowing costs are reshaping where risk and income can come from in your portfolio. That mix creates both pressure and potential opportunity, especially for stocks tied closely to interest rate trends. This article walks through three U.S. life insurance and annuity providers from our screener that appear especially exposed to today’s policy backdrop, and explains why their stories may be relevant as you consider your next move.

The stocks below are just a starting sample, since the full screen surfaced 20 more U.S. life insurers and annuity providers with equally compelling narratives that are not covered here. If you want to go deeper into this idea right now, head straight to the U.S. Life Insurers & Annuity Providers screener to identify, filter and analyze the companies that best fit your own risk and income goals.

Aflac (AFL)

Aflac is a large supplemental health and life insurer that fits the screener’s focus on life insurers with sizable investment portfolios and dividend appeal, while also being sensitive to a higher rate backdrop. The group earns about US$8.9b of revenue from Aflac Japan and US$7.0b from Aflac U.S., along with additional corporate and investment-related items. This results in a business that combines protection products with fixed income spread income. With a market cap of roughly US$58.4b, Aflac is a major player where product refreshes, digital initiatives and rate-driven investment income potential all matter. At the same time, currency exposure to Japan, forecast earnings pressure and funding structure risks mean the full story is more nuanced than the dividend track record alone suggests.

Aflac’s Japan and U.S. engines could be reshaping the story investors think they know. Scan the 3 key rewards and 1 important major warning sign to see how rate sensitivity, currency exposure and that dividend record really fit together.

Globe Life (GL)

Globe Life focuses on life and supplemental health insurance for U.S. households, which fits the screener’s tilt toward long-duration protection businesses that can reinvest at higher yields when rates stay elevated. The company generated about US$3.4b from life insurance, US$1.6b from health products and US$1.2b from its investment portfolio, with smaller contributions from other income and realized gains, all from U.S. customers. With a market cap of about US$13.3b, Globe Life is a mid sized insurer with meaningful exposure to rate sensitive spread income.

Investors looking at Globe Life today are getting a rate sensitive life and health insurer that already has healthy underwriting margins and a history of using excess cash for buybacks and dividends. This is now backed by a fresh US$2.5b repurchase program and a regular US$0.33 quarterly dividend. Higher reinvestment yields can support spread income on its long dated policies, while a growing health book linked to rising healthcare spend and Medicare Supplement demand adds another earnings pillar as inflation and Fed policy reshape financing conditions. The flip side is meaningful leverage, reliance on traditional agents and ongoing regulatory investigations, which together keep execution and funding risk firmly on the radar and make Globe Life a company to study closely rather than assume is a simple rate winner.

Globe Life’s buybacks, dividend and long dated policies could be telling a different story than the headlines. Tap into the 3 key rewards and 1 important warning sign and see what might be quietly driving the next chapter.

Prudential Financial (PRU)

Prudential Financial is a large global life insurer and annuity provider that fits squarely with the screener’s focus on long term savings and retirement income businesses that are closely tied to interest rate trends. It earns about US$18.5b from International Businesses, roughly US$6.8b from U.S. Group Insurance and US$6.3b from U.S. Individual Life, with its PGIM asset management arm contributing about US$4.4b alongside segment adjustments and corporate items. With a market cap of roughly US$41.4b, Prudential Financial gives you exposure to both insurance and a sizeable investment portfolio that can be sensitive to a higher for longer rate backdrop.

Investors watching higher Fed rate hike odds and sticky inflation may see Prudential Financial as a way to link their portfolio to long duration retirement and insurance cash flows that can benefit when long term yields stay elevated. The company combines a global life and annuity franchise with the PGIM asset management platform and a dividend yield above 4%, while working to simplify its product mix, cut costs and reduce sensitivity to older guaranteed blocks. At the same time, reliance on external borrowing, regulatory shifts in key markets like Japan and execution risk around digital and product pivots mean this is not a simple rate trade. The real question is whether Prudential’s balance between income appeal and these moving parts still stacks up in your portfolio.

Prudential Financial’s income story and PGIM engine may be masking what really matters for long term retirement flows. Scan the analyst forecasts for Prudential Financial to see what could be quietly shifting under the surface.

Seeking Alternatives Beyond Life Insurers

Fresh ideas move quickly. Stocks can break out, momentum can build, and quiet opportunities can attract broader attention. Scan these fresh picks while it matters and consider acting early.

• Target reliable income potential and price resilience by scanning a curated 12 dividend fortresses before yields change or quality gets bid up by latecomers.
• Hunt for early movers in infrastructure behind artificial intelligence momentum by reviewing the hand picked 55 AI infrastructure stocks while they remain relatively under the radar.
• Consider positioning for potential upside in companies supplying a critical metal by checking the focused 9 top copper producer stocks before sentiment and prices shift.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com